Search results - 4 results
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
were living with a diagnosed viraemic infection. In 2020, an estimated 641 000 (623 000-765 000) patients initiated treatment. INTERPRETATION: At the beginning of 2020, there were an estimated 56·8 ...
Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method
Addiction Medicine, Virtually (2021) URL: https://www.inhsu.org/2021-conference/ Abstract: Background: In Belgium, people who inject drugs (PWID) are at a high-risk of being infected by hepatitis C (HCV). ...
Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010-2018.
established to date. Here, we report that patients infected with HEV-3c were at lower risk of hospitalisation, compared to those infected with HEV-3f, the other main subtype circulating in Belgium. Health ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
are scarce, and particularly for people who inject drugs. The current study refines the existing HCV estimates by focussing on diagnostic HCV testing practices for this population at risk. METHODS: The ...